SOPH (Sophia Genetics) Change In Inventory: $-1.79 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SOPH Sophia Genetics SA SOPH
67 GF Score
Price $5.67
GF Value $5.09
Valuation Modestly Overvalued
! 6 Warning Signs
View Full Analysis

What is Sophia Genetics Change In Inventory?

Sophia Genetics SOPH -1.39% 67 Change In Inventory is $-1.79 Mil as of Mar. 2026. GuruFocus rates SOPH with a GF Score™ of 67/100 and a GF Value™ of $5.09 (Modestly Overvalued). The stock has 6 warning signs investors should review.

Sophia Genetics's change in inventory for the quarter that ended in Mar. 2026 was $-0.87 Mil. It means Sophia Genetics's inventory increased by $0.87 Mil from Dec. 2025 to Mar. 2026 .

Sophia Genetics's change in inventory for the fiscal year that ended in Dec. 2025 was $0.05 Mil. It means Sophia Genetics's inventory declined by $0.05 Mil from Dec. 2024 to Dec. 2025 .

Sophia Genetics's Total Inventories for the quarter that ended in Mar. 2026 was $7.09 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Sophia Genetics's Days Inventory for the quarter that ended in Mar. 2026 was 88.35.

Inventory Turnover measures how fast the company turns over its inventory within a year. Sophia Genetics's Inventory Turnover for the quarter that ended in Mar. 2026 was 1.03.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Sophia Genetics's Inventory-to-Revenue for the quarter that ended in Mar. 2026 was 0.31.

Sophia Genetics  (NAS:SOPH) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Sophia Genetics's Days Inventory for the quarter that ended in is calculated as:

Days Inventory=Average Total Inventories/Cost of Goods Sold*Days in Period
=6.7185/6.939*365 / 4
=88.35

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Sophia Genetics's Inventory Turnover for the quarter that ended in Mar. 2026 is calculated as

Inventory Turnover=Cost of Goods Sold / Average Total Inventories
=6.939 / 6.7185
=1.03

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Sophia Genetics's Inventory to Revenue for the quarter that ended in Mar. 2026 is calculated as

Inventory-to-Revenue=Average Total Inventories / Revenue
=6.7185 / 21.688
=0.31

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sophia Genetics Change In Inventory Related Terms

Sophia Genetics Change In Inventory Historical Data

* Premium members only.

The historical data trend for Sophia Genetics's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sophia Genetics Change In Inventory Chart

Sophia Genetics Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Change In Inventory
Get a 7-Day Free Trial -2.34 -0.20 -0.87 0.07 0.05

Sophia Genetics Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Change In Inventory Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.97 -0.61 -0.53 0.21 -0.87
SOPH
67GF Score
Sophia Genetics SA SOPH
Change In Inventory is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sophia Genetics Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.79 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Change In Inventory →
What does a Change In Inventory of $-1.79 Mil mean?
Sophia Genetics (SOPH) has a Change In Inventory of $-1.79 Mil as of Mar. 2026. Change in Inventory is the difference between current-period inventory and past-period inventory. View historical data for Sophia Genetics and its competitors.
Is Sophia Genetics' Change In Inventory too high?
Sophia Genetics' current Change In Inventory is $-1.79 Mil. Overall, Sophia Genetics has a GF Score™ of 67/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Sophia Genetics' Change In Inventory compare to EVH and NRC?
Sophia Genetics' Change In Inventory of $-1.79 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Change In Inventory for a Healthcare Providers & Services company?
A good Change In Inventory depends on the Healthcare Providers & Services industry context. However, Change In Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Change In Inventory mean?
A high Change In Inventory can signal that a stock is expensive relative to its fundamentals. Change in Inventory is the difference between current-period inventory and past-period inventory. View historical data for Sophia Genetics and its competitors. Sophia Genetics's current Change In Inventory is $-1.79 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sophia Genetics stock overvalued right now?
Based on GuruFocus' analysis, Sophia Genetics (SOPH) is currently considered Modestly Overvalued. The stock's GF Value™ is $5.09, compared to a current price of $5.67 — trading 11.4% above its estimated fair value. The current Change In Inventory is $-1.79 Mil. Sophia Genetics' overall GF Score™ is 67/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Change In Inventory calculated?
Change In Inventory is calculated from a company's financial statements. For Sophia Genetics (SOPH), the current Change In Inventory is $-1.79 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sophia Genetics (SOPH) Overvalued in 2026?

Based on GuruFocus' analysis, Sophia Genetics stock appears to be overvalued. The current stock price of $5.67 is trading 11.4% above its estimated GF Value™ of $5.09. GuruFocus considers Sophia Genetics to be Modestly Overvalued.

Key valuation signals for SOPH:

  • Change In Inventory: $-1.79 Mil
  • GF Value™: $5.09 vs. price of $5.67 (11.4% above fair value)
  • GF Score™: 67/100 with 6 warning signs

No single metric tells the full story. See the SOPH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Sophia Genetics Business Description

Other Exchanges 90B:Germany
Address La Piece 12, Rolle, CHE, CH-1180
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.
67GF Score

Get the complete analysis for SOPH

Change In Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$5.67
Price
$5.09
GF Value